Jacobs Levy Equity Management’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
APM
LPC
Jacobs Levy Equity Management's BLUE Position: Q3 2024 in Review
Jacobs Levy Equity Management sold out of bluebird bio (BLUE) in Q3 2024, closing a stake of 16,635 shares — an estimated $327K sold.
Jacobs Levy Equity Management first reported a position in BLUE in Q1 2018 and held it in 18 quarters. The position peaked at $25.9M in Q2 2021. 140 funds tracked by Wall St. Rank hold BLUE as of Q3 2024.
- Jacobs Levy Equity Management reported no remaining bluebird bio position as of Q3 2024 after selling out during the quarter.
- Jacobs Levy Equity Management sold 16,635 bluebird bio shares in Q3 2024, an estimated $327K.
- Jacobs Levy Equity Management first reported a position in bluebird bio in Q1 2018 and held it in 18 quarters.
- Jacobs Levy Equity Management's bluebird bio position peaked at $25.9M in Q2 2021.
- 140 funds tracked by Wall St. Rank held bluebird bio as of Q3 2024.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2024, filed 14 Nov 2024.